HealthInvest Partners AB Purchases New Shares in Shockwave Medical, Inc. (NASDAQ:SWAV)

HealthInvest Partners AB purchased a new position in Shockwave Medical, Inc. (NASDAQ:SWAV - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 3,530 shares of the company's stock, valued at approximately $673,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of SWAV. Lindbrook Capital LLC increased its holdings in Shockwave Medical by 64.8% during the 3rd quarter. Lindbrook Capital LLC now owns 150 shares of the company's stock worth $30,000 after purchasing an additional 59 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of Shockwave Medical by 297.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company's stock worth $31,000 after purchasing an additional 116 shares during the last quarter. Asset Management One Co. Ltd. bought a new stake in Shockwave Medical during the fourth quarter valued at about $34,000. PenderFund Capital Management Ltd. purchased a new position in Shockwave Medical in the first quarter valued at about $41,000. Finally, Operose Advisors LLC purchased a new stake in Shockwave Medical during the third quarter valued at approximately $49,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Activity

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of the company's stock in a transaction on Friday, January 26th. The shares were sold at an average price of $224.69, for a total transaction of $898,760.00. Following the completion of the transaction, the insider now directly owns 63,920 shares in the company, valued at $14,362,184.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Isaac Zacharias sold 4,000 shares of the business's stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $224.69, for a total transaction of $898,760.00. Following the transaction, the insider now directly owns 63,920 shares in the company, valued at $14,362,184.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Trinh Phung sold 1,287 shares of the business's stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $232.18, for a total value of $298,815.66. Following the transaction, the vice president now owns 32,933 shares in the company, valued at $7,646,383.94. The disclosure for this sale can be found here. Insiders have sold 93,813 shares of company stock worth $23,762,679 in the last quarter. Corporate insiders own 3.40% of the company's stock.

Shockwave Medical Stock Performance

NASDAQ SWAV traded up $0.40 during mid-day trading on Tuesday, reaching $327.50. 1,249,317 shares of the stock were exchanged, compared to its average volume of 954,955. Shockwave Medical, Inc. has a 1 year low of $157.00 and a 1 year high of $331.58. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The business's 50 day moving average is $278.57 and its 200-day moving average is $225.46. The company has a market capitalization of $12.25 billion, a P/E ratio of 84.63, a P/E/G ratio of 2.45 and a beta of 0.92.

Shockwave Medical (NASDAQ:SWAV - Get Free Report) last posted its earnings results on Thursday, February 15th. The company reported $1.16 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.24. The firm had revenue of $202.98 million for the quarter, compared to analysts' expectations of $199.43 million. Shockwave Medical had a return on equity of 23.97% and a net margin of 20.17%. The company's quarterly revenue was up 41.0% on a year-over-year basis. During the same period last year, the firm earned $3.71 EPS. On average, equities research analysts forecast that Shockwave Medical, Inc. will post 4.9 EPS for the current fiscal year.

Analysts Set New Price Targets

SWAV has been the subject of several analyst reports. Morgan Stanley reiterated an "equal weight" rating and set a $335.00 price objective (up previously from $285.00) on shares of Shockwave Medical in a report on Monday, April 8th. Needham & Company LLC reissued a "hold" rating on shares of Shockwave Medical in a report on Friday, April 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $335.00 price objective (up from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Leerink Partnrs downgraded shares of Shockwave Medical from an "outperform" rating to a "market perform" rating in a research note on Friday, April 5th. Finally, Piper Sandler upped their target price on Shockwave Medical from $290.00 to $360.00 and gave the company an "overweight" rating in a research report on Tuesday, April 2nd. Ten equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $309.11.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.